Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share Latest Annual | ZIMLAB FY26 | ANUHPHR FY26 | VALIANTLAB FY26 | AHCL FY26 | Peer Average | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 118.71× | 19.42× | — | ◆ 4.00× | 11.71× +914% | |
| P/B | 2.55× | 2.27× | 2.20× | ◆ 0.56× | 1.68× +52% | |
| EV/EBITDA | 27.83× | 12.07× | 108.79× | ◆ 4.08× | 41.64× -33% | |
| Market Cap | ₹756 Cr | ₹798 Cr | ₹683 Cr | ₹130 Cr | ₹537 Cr +41% | |
| Growth | ||||||
| Revenue CAGR 3Y | -2.06% | — | — | — | — | |
| Net Income CAGR 3Y | -37.95% | — | — | — | — | |
| Revenue YoY (latest Q) | 31.25% | 3.93% | ◆ 146.22% | — | 75.08% -58% | |
| Net Income YoY (latest Q) | -114.25% | 37.63% | ◆ 1058.93% | — | 548.28% -121% | |
| Profitability | ||||||
| EBITDA Margin | 8.02% | 8.00% | 2.69% | ◆ 27.63% | 12.77% -37% | |
| Net Income Margin | 1.56% | 5.32% | -1.38% | ◆ 16.92% | 6.95% -78% | |
| Return on Common Equity | 2.13% | 12.10% | -1.20% | ◆ 12.38% | 7.76% -73% | |
| Return on Capital Employed | 3.06% | 14.75% | 0.10% | ◆ 17.26% | 10.70% -71% | |
| Return on Assets | 1.15% | 7.72% | -0.76% | ◆ 7.78% | 4.91% -77% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.42× | ◆ 0.00× | 0.14× | 0.17× | 0.10× +306% | |
| Interest Coverage | 0.76× | ◆ 106.58× | 0.18× | 12.30× | 39.69× -98% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹374 Cr | ₹772 Cr | ₹237 Cr | ₹172 Cr | ₹394 Cr -5% | |
| Net Income | ₹5.8 Cr | ₹41 Cr | −₹3.3 Cr | ₹29.1 Cr | ₹22.3 Cr -74% | |
| Total Assets | ₹539 Cr | ₹557 Cr | ₹464 Cr | ₹374 Cr | ₹465 Cr +16% | |
| EPS | ₹1.19 | ₹4.1 | ₹-0.51 | ₹6.11 | ₹3.23 -63% | |
| Book Value per Share | ₹55.36 | ₹35.14 | ₹57.24 | ₹43.32 | ₹45.23 +22% | |